PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Clinical trials for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS, CASTRATION-RESISTANT trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktails tested in fight against spreading prostate cancer
Disease control OngoingThis study is testing several combinations of the drug niraparib with other cancer treatments for men with metastatic castration-resistant prostate cancer (mCRPC), a serious, advanced form of the disease. The main goals are to find safe and effective doses and to see how well the…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Scientists test drug mix safety for advanced prostate cancer
Knowledge-focused OngoingThis study aims to understand how a prostate cancer drug called JNJ-56021927 affects the way the body processes other common medications. It involves 23 men with advanced prostate cancer that no longer responds to standard hormone therapy. Researchers are measuring drug levels in…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE1 • Sponsor: Aragon Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC